5Z-7-Oxozeaenol

Suppliers

Names

[ Name ]:
5Z-7-Oxozeaenol

[Synonym ]:
(3s,5z,8s,9s,11e)-8,9,16-Trihydroxy-14-Methoxy-3-Methyl-3,4,9,10-Tetrahydro-1h-2-Benzoxacyclotetradecine-1,7(8h)-Dione
LL-Z1640-2
AmbotzLS-1148
5Z-7-Oxozeaenol

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₉H₂₂O₇

[ Molecular Weight ]:
362.37400

[ Exact Mass ]:
362.13700

[ PSA ]:
113.29000

[ LogP ]:
1.60020

[ Storage condition ]:
2-8℃

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301

[ Precautionary Statements ]:
P301 + P310

[ RIDADR ]:
UN 2811 6.1 / PGIII

Precursor & DownStream

Precursor

DownStream

Articles

Docosahexaenoic acid and eicosapentaenoic acid suppress adhesion molecule expression in human aortic endothelial cells via differential mechanisms.

Mol. Nutr. Food. Res. 59(4) , 751-62, (2015)

Dietary PUFAs modulate the progression of cardiovascular disease, but the underlying mechanisms within vascular cells remain unclear. The aim of this study was to investigate the biological function a...

Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood.

Inflammation 38(2) , 858-70, (2015)

Cyclooxygenase 2 (COX-2) and the production of cytokines/chemokines are important targets for the modulation of the inflammatory response. Although a large variety of inhibitors of these pathways have...

Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.

Redox Biol. 5 , 319-27, (2016)

Transforming growth factor β-activated kinase 1 (TAK1) is critical for survival of many KRAS mutated colorectal cancer cells, and TAK1 inhibition with 5Z-7-oxozeaenol has been associated with oxidativ...

(5Z)-7-Oxozeaenol
(5Z)-7-[(1S,5R)-6,6-Dimethyl-3β-[(1-oxohexyl)amino]bicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid
(5Z)-7-[(1α,4α)-3β-[(1E,3S)-3-Hydroxy-1-octenyl]-7-oxabicyclo[2.2.1]heptane-2α-yl]-5-heptenoic acid
(5Z)-7-<3-endo-(benzoylamino)bicyclo<2.2.1>hept-2-exo-yl>heptenoic acid sodium salt
(5Z)-7-<(1R*,2S*,3S*,4S*)-3-phenylsulphonylaminobicyclo<2.2.1>-hept-2-yl>hept-5-enoic acid
(5Z)-7-{(2R)-2-[(1E,3S)-7-Ethoxy-3-hydroxy-1-hepten-1-yl]-3,5-dihydroxycyclopentyl}-5-heptenoic acid
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
1-[7-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)heptanoyl]-4-methylpyrrolidine-3-carboxylic acid
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine
3-{5-Azaspiro[2.4]heptan-5-yl}-4-methylcyclohexan-1-one